Group One Trading’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,000
| Closed | -$24.7K | – | 8586 |
|
|
2024
Q4 | $24.7K | Sell |
2,000
-66,800
| -97% | -$765K | ﹤0.01% | 5558 |
|
|
2024
Q3 | $783K | Sell |
68,800
-2,000
| -3% | -$20.1K | ﹤0.01% | 2506 |
|
|
2024
Q2 | $506K | Buy |
70,800
+3,900
| +6% | +$29.8K | ﹤0.01% | 2557 |
|
|
2024
Q1 | $448K | Buy |
+66,900
| New | +$460K | ﹤0.01% | 2845 |
|
|
2023
Q4 | – | Sell |
-5,000
| Closed | -$47.2K | – | 8351 |
|
|
2023
Q3 | $47.2K | Buy |
5,000
+1,100
| +28% | +$13.2K | ﹤0.01% | 5155 |
|
|
2023
Q2 | $54.5K | Sell |
3,900
-2,400
| -38% | -$40.9K | ﹤0.01% | 5198 |
|
|
2023
Q1 | $118K | Sell |
6,300
-6,300
| -50% | -$103K | ﹤0.01% | 4155 |
|
|
2022
Q4 | $174K | Sell |
12,600
-6,800
| -35% | -$104K | ﹤0.01% | 3976 |
|
|
2022
Q3 | $371K | Buy |
19,400
+12,100
| +166% | +$220K | ﹤0.01% | 3523 |
|
|
2022
Q2 | $111K | Buy |
7,300
+4,300
| +143% | +$63.6K | ﹤0.01% | 4890 |
|
|
2022
Q1 | $61K | Buy |
+3,000
| New | +$61.1K | ﹤0.01% | 5956 |
|
|
2021
Q4 | – | Sell |
-100
| Closed | -$2K | – | 8969 |
|
|
2021
Q3 | $2K | Sell |
100
-100
| -50% | -$2.41K | ﹤0.01% | 7978 |
|
|
2021
Q2 | $5K | Buy |
+200
| New | +$4.27K | ﹤0.01% | 7786 |
|
|
2021
Q1 | – | Sell |
-2,100
| Closed | -$24K | – | 8124 |
|
|
2020
Q4 | $24K | Buy |
+2,100
| New | +$19.2K | ﹤0.01% | 5428 |
|
|
2020
Q3 | – | Sell |
-10,200
| Closed | -$67K | – | 6628 |
|
|
2020
Q2 | $67K | Sell |
10,200
-3,600
| -26% | -$20.1K | ﹤0.01% | 4177 |
|
|
2020
Q1 | $71K | Buy |
13,800
+12,200
| +763% | +$73.8K | ﹤0.01% | 3523 |
|
|
2019
Q4 | $12K | Buy |
+1,600
| New | +$9.34K | ﹤0.01% | 4554 |
|
|
2019
Q3 | – | Sell |
-700
| Closed | -$4K | – | 5651 |
|
|
2019
Q2 | $4K | Buy |
+700
| New | +$2.89K | ﹤0.01% | 4657 |
|
|
2018
Q4 | – | Sell |
-8,900
| Closed | -$61K | – | 5520 |
|
|
2018
Q3 | $61K | Hold |
8,900
| – | – | ﹤0.01% | 3849 |
|
|
2018
Q2 | $35K | Buy |
8,900
+1,100
| +14% | +$3.82K | ﹤0.01% | 4137 |
|
|
2018
Q1 | $23K | Hold |
7,800
| – | – | ﹤0.01% | 4035 |
|
|
2017
Q4 | $30K | Hold |
7,800
| – | – | ﹤0.01% | 3993 |
|
|
2017
Q3 | $24K | Buy |
+7,800
| New | +$29.3K | ﹤0.01% | 3989 |
|
|
2016
Q1 | – | Sell |
-3,229
| Closed | -$26K | – | 5030 |
|
|
2015
Q4 | $26K | Sell |
3,229
-1,742
| -35% | -$14.1K | ﹤0.01% | 3785 |
|
|
2015
Q3 | $36K | Buy |
4,971
+2,442
| +97% | +$20.4K | ﹤0.01% | 3738 |
|
|
2015
Q2 | $23K | Buy |
2,529
+600
| +31% | +$5.77K | ﹤0.01% | 3976 |
|
|
2015
Q1 | $18K | Sell |
1,929
-2,271
| -54% | -$21.9K | ﹤0.01% | 3942 |
|
|
2014
Q4 | $41K | Sell |
4,200
-5,500
| -57% | -$55.4K | ﹤0.01% | 3502 |
|
|
2014
Q3 | $92K | Sell |
9,700
-3,071
| -24% | -$34.4K | ﹤0.01% | 3077 |
|
|
2014
Q2 | $168K | Sell |
12,771
-1,372
| -10% | -$17.3K | ﹤0.01% | 2577 |
|
|
2014
Q1 | $188K | Buy |
14,143
+614
| +5% | +$8.08K | ﹤0.01% | 2491 |
|
|
2013
Q4 | $132K | Sell |
13,529
-14,128
| -51% | -$133K | ﹤0.01% | 2797 |
|
|
2013
Q3 | $273K | Buy |
27,657
+8,071
| +41% | +$80.2K | 0.01% | 2116 |
|
|
2013
Q2 | $177K | Buy |
+19,586
| New | +$205K | ﹤0.01% | 2297 |
|
Other funds holding CDMO
Group One Trading's CDMO Position: Q1 2025 in Review
Group One Trading sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 3,338 shares — an estimated $41.2K sold.
Group One Trading first reported a position in CDMO in Q2 2013 and held it in 35 quarters. The position peaked at $252K in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Group One Trading reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Group One Trading sold 3,338 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $41.2K.
- Group One Trading first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 35 quarters.
- Group One Trading's Avid Bioservices, Inc. Common Stock position peaked at $252K in Q4 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.